Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

561 trials

NCT05044962
Recruiting
Kuwa Free! - Live Free!
Not applicable · Kenya · 1 site
Registry update: 13 Apr 2026
NCT04725617
Recruiting
Wellness Intervention for Smoking and HIV
Not applicable · United States · 2 sites
Registry update: 19 Aug 2025
NCT05159466
Recruiting
Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors
Not applicable · United States · 1 site
Registry update: 2 Oct 2025
NCT04787848
Recruiting
Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics
Not applicable · United States · 1 site
Registry update: 11 Sept 2026
NCT05147519
Recruiting
Protocol RV 583 Multinational Observational Cohort of HIV and Other Infections
Not applicable · Kenya, Nigeria, Philippines, Uganda · 4 sites
Registry update: 28 May 2026
NCT05165745
Recruiting
Stick2PrEP Cisgender Women and Trans Individuals
Not applicable · United States · 1 site
Registry update: 2 Sept 2025
NCT05231135
Recruiting
A Registry Study on HIV-related Lymphoma
Not applicable · Germany, Spain, United Kingdom, Netherlands · 6 sites
Registry update: 6 Apr 2023
NCT04810858
Recruiting
Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury
Not applicable · United States · 1 site
Registry update: 31 Mar 2026
NCT04855773
Recruiting
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
Not applicable · United States · 4 sites
Registry update: 28 Sept 2022
NCT04958122
Recruiting
Cefixime Clinical Trial
Phase 3 · United States · 1 site
Registry update: 4 May 2026
NCT04979728
Recruiting
HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots
Not applicable · United States · 1 site
Registry update: 3 Mar 2026
NCT04139304
Recruiting
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
Early phase 1 · United States · 9 sites
Registry update: 28 Oct 2026
NCT04319367
Recruiting
A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
Phase 2 · Belgium, Germany, Denmark, Spain, United Kingdom, Netherlands, Sweden · 17 sites
Registry update: 17 Apr 2024
NCT04875819
Recruiting
Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV
Phase 4 · Denmark · 2 sites
Registry update: 6 May 2021
NCT04700579
Recruiting
Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis
Not applicable · South Africa · 3 sites
Registry update: 6 May 2026
NCT04375800
Recruiting
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
Phase 2 · Colombia, Dominican Republic, Guatemala, Mexico, Russia, Thailand, United States, South Africa · 26 sites
Registry update: 27 Oct 2026
NCT04760574
Recruiting
Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism
Not applicable · Taiwan · 1 site
Registry update: 3 Mar 2021
NCT04653610
Recruiting
Sequential Analysis Before and After Treatment Initiation to Unravel the Role of Naturally Occurring Extracellular Vesicles in HIV Infection
Not applicable · Belgium · 1 site
Registry update: 8 Feb 2024
NCT04359186
Recruiting
SCOPE Analytic Treatment Interruption Protocol
Not applicable · United States · 1 site
Registry update: 23 Jan 2026
NCT04405700
Recruiting
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Not applicable · Kenya · 1 site
Registry update: 24 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.